Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)

Respiratory Syncytial Virus infections are one of the leading causes of severe respiratory diseases that require hospitalization and, in some cases, intensive care. Once resolved, there may be respiratory sequelae of varying severity. The lack of effective treatments for bronchiolitis and the lack o...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ital J Pediatr
Asıl Yazarlar: Bollani, Lina, Baraldi, Eugenio, Chirico, Gaetano, Dotta, Andrea, Lanari, Marcello, Del Vecchio, Antonello, Manzoni, Paolo, Boldrini, Antonio, Paolillo, Piermichele, Di Fabio, Sandra, Orfeo, Luigi, Stronati, Mauro, Romagnoli, Costantino
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2015
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4681171/
https://ncbi.nlm.nih.gov/pubmed/26670908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13052-015-0203-x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller